On July 31, 2024, the Food and Drug Administration conducted a post-market assurance inspection at IRhythm Technologies, Inc. in San Francisco, resulting in three citations.
The Food and Drug Administration (FDA) conducted an inspection of IRhythm Technologies, Inc. in San Francisco on July 31, 2024, focusing on device compliance and issued three citations, according to information available on the FDA’s official website.
On August 26, 2024, the Food and Drug Administration (FDA) conducted a post-market assurance inspection of Ceevra, Inc. in San Francisco, resulting in one citation according to FDA records.
On December 12, 2024, the FDA conducted a bioresearch monitoring inspection of Julia C. Carnevale, M.D. in San Francisco, resulting in 13 citations.
Mark Savant, M.D., based in San Francisco, underwent an FDA bioresearch monitoring inspection on April 17, 2024, resulting in three citations according to FDA records.
On September 17, 2024, the Food and Drug Administration (FDA) conducted an inspection of Nest Cryobank, LLC in San Francisco focused on human cellular, tissue, and gene therapies, resulting in one citation, according to the FDA’s official website.
In 2024, 99.2% of H-1B petitions filed by Educational Services employers across San Francisco Sun publication area were approved, according to data from the U.S. Citizenship and Immigration Services via the H-1B Employer Data Hub.
On May 23, 2024, the Food and Drug Administration conducted an inspection of Lotus Bakeries North America, Inc. in San Francisco, identifying one citation related to foodborne biological hazards, according to FDA records.
On August 26, 2024, the Food and Drug Administration (FDA) conducted an inspection of Ceevra, Inc. in San Francisco for device compliance and issued one citation, according to information available on the FDA’s official website.
On July 29, 2024, the Food and Drug Administration (FDA) conducted an inspection of Golden Gate Soy Products, Inc. in San Francisco, focusing on food composition, standards, labeling, and economic factors, resulting in one citation, according to information on the FDA’s official website.